Anna Bertolini

689 total citations
21 papers, 484 citations indexed

About

Anna Bertolini is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Anna Bertolini has authored 21 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Anna Bertolini's work include Drug Transport and Resistance Mechanisms (4 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Cystic Fibrosis Research Advances (4 papers). Anna Bertolini is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Cystic Fibrosis Research Advances (4 papers). Anna Bertolini collaborates with scholars based in Netherlands, Italy and United States. Anna Bertolini's co-authors include Mario Strazzabosco, Romina Fiorotto, Johan W. Jonker, Henkjan J. Verkade, Ivo P. van de Peppel, Frank A.J.A. Bodewes, Alberto Fantin, Fabio Farinati, Han Moshage and Giulia Peserico and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Scientific Reports.

In The Last Decade

Anna Bertolini

19 papers receiving 478 citations

Peers

Anna Bertolini
Anna Bertolini
Citations per year, relative to Anna Bertolini Anna Bertolini (= 1×) peers Maria Grazia Radaelli

Countries citing papers authored by Anna Bertolini

Since Specialization
Citations

This map shows the geographic impact of Anna Bertolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bertolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bertolini more than expected).

Fields of papers citing papers by Anna Bertolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Bertolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bertolini. The network helps show where Anna Bertolini may publish in the future.

Co-authorship network of co-authors of Anna Bertolini

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Bertolini. A scholar is included among the top collaborators of Anna Bertolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Bertolini. Anna Bertolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertolini, Anna, et al.. (2025). Pathophysiology of cystic fibrosis-related liver disease. Current Opinion in Gastroenterology. 42(2). 83–89.
2.
Franceschini, Davide, Mauro Loi, Luca Dominici, et al.. (2024). STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung Lesions. SHILAP Revista de lepidopterología. 12(7). 153–153. 2 indexed citations
3.
Franzese, Ciro, Anna Bertolini, Davide Franceschini, et al.. (2024). Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR). Cancers. 16(17). 2963–2963. 2 indexed citations
4.
Bertolini, Anna, et al.. (2024). Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice. Journal of Hepatology. 81(3). 429–440. 5 indexed citations
5.
Fogliata, Antonella, Davide Franceschini, Ruggero Spoto, et al.. (2024). Adjuvant Hypofractionated Whole Breast Irradiation (WBI) vs. Accelerated Partial Breast Irradiation (APBI) in Postmenopausal Women with Early Stage Breast Cancer: 5Years Update of the HYPAB Trial. Clinical Breast Cancer. 24(3). 253–260. 2 indexed citations
6.
Bertolini, Anna, Vincent W. Bloks, Ivo P. van de Peppel, et al.. (2023). Treatment of intestinal and liver features in cystic fibrosis mice by the osmotic laxative polyethylene glycol. Journal of Cystic Fibrosis. 23(3). 461–473. 3 indexed citations
7.
Bertolini, Anna, Miriam Rigoldi, Raffaella Mariani, et al.. (2023). Long-term outcome of a cohort of Italian patients affected with alpha-Mannosidosis. Clinical Dysmorphology. 33(1). 1–8. 3 indexed citations
9.
Bertolini, Anna, Romina Fiorotto, & Mario Strazzabosco. (2022). Bile acids and their receptors: modulators and therapeutic targets in liver inflammation. Seminars in Immunopathology. 44(4). 547–564. 88 indexed citations
10.
Fugazzaro, Stefania, et al.. (2022). Sex differences and rehabilitation needs after hospital discharge for COVID-19: an Italian cross-sectional study. BMJ Open. 12(5). e055308–e055308. 7 indexed citations
11.
Bertolini, Anna, Ivo P. van de Peppel, Rick Havinga, Johan W. Jonker, & Henkjan J. Verkade. (2022). The Apical Sodium-Dependent Bile Acid Transporter in Cholangiocytes Is Not Required for the Generation of Bile Flow in Mice. SHILAP Revista de lepidopterología. 1(3). 375–377.
12.
Fugazzaro, Stefania, et al.. (2022). “Like before, but not exactly”: the Qualy-REACT qualitative inquiry into the lived experience of long COVID. BMC Public Health. 22(1). 599–599. 27 indexed citations
13.
Verkade, Henkjan J., Anna Bertolini, Sanne de Wit, et al.. (2021). Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia. Scientific Reports. 11(1). 11107–11107. 16 indexed citations
14.
Bertolini, Anna, Ivo P. van de Peppel, Frank A.J.A. Bodewes, et al.. (2020). Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis. Hepatology. 72(5). 1864–1872. 195 indexed citations
15.
Zutphen, Tim van, Anna Bertolini, H. de Vries, et al.. (2019). Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease. Handbook of experimental pharmacology. 256. 207–234. 22 indexed citations
16.
Peppel, Ivo P. van de, Anna Bertolini, Theo H. van Dijk, et al.. (2019). Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in mice. Journal of Lipid Research. 60(9). 1562–1572. 20 indexed citations
17.
Zonneveld, Rens, et al.. (2017). Improved referral and survival of newborns after scaling up of intensive care in Suriname. BMC Pediatrics. 17(1). 189–189. 12 indexed citations
18.
Peppel, Ivo P. van de, Anna Bertolini, Johan W. Jonker, Frank A.J.A. Bodewes, & Henkjan J. Verkade. (2017). Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease. Current Opinion in Pulmonary Medicine. 23(6). 562–569. 17 indexed citations
19.
Corollaro, Maria Laura, Isabella Endrizzi, Anna Bertolini, et al.. (2012). Sensory profiling of apple: Methodological aspects, cultivar characterisation and postharvest changes. Postharvest Biology and Technology. 77. 111–120. 49 indexed citations
20.
Castelli, M., et al.. (1987). Bactericidal and Antineoplastic Effect of Combination of Norfloxacin and Adriamycin. Chemotherapy. 33(5). 355–360. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026